Manchester Capital Management’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-26,880
| Closed | -$201K | – | 1032 |
|
|
2023
Q2 | $201K | Hold |
26,880
| – | – | 0.03% | 271 |
|
|
2023
Q1 | $179K | Hold |
26,880
| – | – | 0.02% | 298 |
|
|
2022
Q4 | $207K | Hold |
26,880
| – | – | 0.03% | 248 |
|
|
2022
Q3 | $286K | Buy |
26,880
+13,440
| +100% | +$143K | 0.05% | 179 |
|
|
2022
Q2 | $109K | Hold |
13,440
| – | – | 0.02% | 283 |
|
|
2022
Q1 | $96K | Buy |
+13,440
| New | +$96K | 0.01% | 342 |
|